The role of peroxisome proliferator-activated receptors (PPAR) in immune responses

被引：368
作者：
Christofides, Anthos [1 ,2 ,3 ]
Konstantinidou, Eirini [1 ,2 ,3 ]
Jani, Chinmay [2 ,4 ]
Boussiotis, Vassiliki A. [1 ,2 ,3 ]
机构：
[1] Harvard Med Sch, Div Hematol Oncol, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02215 USA
[3] Harvard Med Sch, Ctr Canc, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Mt Auburn Hosp, Dept Med, Cambridge, MA 02138 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 114卷
基金：
美国国家卫生研究院;
关键词：
PPAR; Metabolism; Inflammation; T cells; Myeloid cells; FATTY-ACID OXIDATION; REGULATE MACROPHAGE POLARIZATION; FOAM-CELL-FORMATION; RAT ADIPOSE-TISSUE; DELTA AGONIST; GENE-EXPRESSION; T-CELLS; MESSENGER-RNA; BETA/DELTA ACTIVATION; TRANSCRIPTION FACTOR;
D O I：
10.1016/j.metabol.2020.154338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Peroxisome proliferator-activated receptors (PPARs) are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that regulate energy metabolism. Currently, three PPAR subtypes have been identified: PPAR alpha, PPAR gamma, and PPAR beta/6. PPAR alpha and PPAR6 are highly expressed in oxidative tissues and regulate genes involved in substrate delivery and oxidative phosphorylation (OXPHOS) and regulation of energy homeostasis. In contrast, PPAR gamma is more important in lipogenesis and lipid synthesis, with highest expression levels in white adipose tissue (WAT). In addition to tissues regulating whole body energy homeostasis, PPARs are expressed in immune cells and have an emerging critical role in immune cell differentiation and fate commitment. In this review, we discuss the actions of PPARs in the function of the innate and the adaptive immune system and their implications in immune-mediated inflammatory conditions. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数：13
相关论文
共 187 条
  • [91] Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and β
    Li, AC
    Binder, CJ
    Gutierrez, A
    Brown, KK
    Plotkin, CR
    Pattison, JW
    Valledor, AF
    Davis, RA
    Willson, TM
    Witztum, JL
    Palinski, W
    Glass, CK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (11) : 1564 - 1576
  • [92] Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice
    Li, G.
    Chen, C.
    Laing, S. D.
    Ballard, C.
    Biju, K. C.
    Reddick, R. L.
    Clark, R. A.
    Li, S.
    [J]. GENE THERAPY, 2016, 23 (01) : 78 - 85
  • [93] Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction
    Li, Shenyang
    Mariappan, Nithya
    Megyesi, Judit
    Shank, Brian
    Kannan, Krishnaswamy
    Theus, Sue
    Price, Peter M.
    Duffield, Jeremy S.
    Portilla, Didier
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (05) : F618 - F627
  • [94] T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor γ binding properties
    Li, Yang
    Wang, Zhulun
    Furukawa, Noboru
    Escaron, Patrick
    Weiszmann, Jennifer
    Lee, Gary
    Lindstrom, Michelle
    Liu, Jinsong
    Liu, Xiaohong
    Xu, Haoda
    Plotnikova, Olga
    Prasad, Vidya
    Walker, Nigel
    Learned, R. Marc
    Chen, Jin-Long
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (14) : 9168 - 9176
  • [95] Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ Expression
    Lian, Min
    Luo, Wenjing
    Sui, Yongheng
    Li, Zhiping
    Hua, Jing
    [J]. PLOS ONE, 2015, 10 (07):
  • [96] Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice
    Liang, Yao-Jen
    Chen, Siang-An
    Jian, Jhih-Hao
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (1-2) : 65 - 70
  • [97] Quantitative PPARγ expression affects the balance between tolerance and immunity
    Liu, Ya-Hui
    Tsai, Yau-Sheng
    Lin, Shih-Chieh
    Liao, Nan-Shih
    Jan, Ming-Shiou
    Liang, Chung-Tiang
    Hsu, Shih-Wen
    Chen, Wen-Chung
    Sung, Junne-Ming
    Maeda, Nobuyo
    Tsai, Pei-Jane
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [98] Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease
    Luo, Wenjing
    Xu, Qinyu
    Wang, Qi
    Wu, Huimin
    Hua, Jing
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [99] Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-α control of the acute-phase response
    Mansouri, Roxane M.
    Bauge, Eric
    Staels, Bart
    Gervois, Philippe
    [J]. ENDOCRINOLOGY, 2008, 149 (06) : 3215 - 3223
  • [100] Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport
    Michaelis, Martin
    Rothweiler, Florian
    Wurglics, Mario
    Aniceto, Natalia
    Dittrich, Michaela
    Zettl, Heiko
    Wiese, Michael
    Wass, Mark
    Ghafourian, Taravat
    Schubert-Zsilavecz, Manfred
    Cinatl, Jindrich
    [J]. ONCOTARGET, 2016, 7 (10): : 11664 - 11676
567891011121314